Nalu Medical
Nalu Medical is a medical device company that develops the battery-free, micro-implantable Nalu Neurostimulation System for chronic pain management.
Secondary Market Price
How Nalu Medical Measures Up
To help you manage your Nalu Medical equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series E
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Nalu Medical's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Nalu Medical Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Nalu Medical's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Nalu Medical, a medical device company founded in 2014, develops and commercializes neurostimulation systems for chronic pain management. Headquartered in Carlsbad, California, the company's primary product is a battery-free, micro-implantable pulse generator (iPG) system. This device has received FDA clearance for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) to treat chronic pain. The company has engaged in clinical research, including its COMFORT Randomized Controlled Trial, to validate the system's effectiveness.
A significant recent development for Nalu Medical is its acquisition by Boston Scientific, integrating the company into Boston Scientific's Pain Management division. This move is expected to expand the company's reach and advance its pain management solutions. Prior to the acquisition, Nalu announced the 24-month results from its COMFORT trial, which demonstrated a 67% average reduction in pain and an 85% responder rate among participants. As part of Boston Scientific, the company is expected to continue its focus on clinical research, product innovation, and educational outreach within the medical community.
- Novo Holdings
- B Capital
- Gilde Healthcare
- MVM Partners
- Endeavour Vision
- Decheng Capital
- Longitude Capital
- Advent Life Sciences
- Pura Vida
- Aperture Venture Partners
- Co-Founder, Lee Hartley
- Co-Founder, Daniel Pivonka
- Co-Founder, Mike Partsch
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Nalu Medical worth joining?
Deciding whether to join any company is a personal choice that depends on your career goals, the role, and the company culture. To help you evaluate the financial upside, platforms like Prospect can model the potential future value of your equity compensation.
What should I do with my Nalu Medical stock?
Managing private company stock requires careful planning around taxes and timing to maximize its value. Tools like Prospect can build a customized strategy for your holdings, helping you decide when to exercise options or sell shares.
Can you sell Nalu Medical stock?
Selling stock in a private company is often possible through company-approved tender offers or on secondary markets, though there may be restrictions. Platforms like Prospect offer tools to help you navigate these opportunities and determine which shares are most tax-optimal to sell.
How can I find the value of my Nalu Medical stock?
Since Nalu Medical is a private company, its stock value isn't publicly listed and can be difficult to determine. You can use a platform like Prospect, which uses machine learning models to project the value of private company equity based on market data and company performance signals.
What is Nalu Medical's equity worth?
The precise value of a private company's equity is not public information and depends on factors like its latest valuation and your specific grant details. To get a personalized estimate, you can use services like Prospect to model your equity's potential worth based on your financial situation and proprietary market data.
What is Nalu Medical's stock ticker symbol?
As a private company, Nalu Medical does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange like the NYSE or NASDAQ.
Can I buy or sell Nalu Medical stock?
Buying stock in a private company like Nalu Medical is generally restricted to employees or accredited investors during specific funding rounds. Selling is sometimes possible for employees during liquidity events like tender offers, and platforms like Prospect can help you analyze these opportunities.
What is the criteria to buy or invest in Nalu Medical stock?
Investing in a private company like Nalu Medical is typically not open to the general public. Opportunities to buy stock are usually limited to employees as part of their compensation or to accredited investors who are invited to participate in private financing rounds.
